What do pharma leaders say about AI when the doors are closed? Earlier this year, we brought together 31 senior […]
Pharmacogenomics has transformed how clinicians reduce adverse drug reactions and optimise therapy. But real-world implementation still faces significant limitations. What […]
Written by Vered Smith, science writer A report has been published by the Royal College of Physicians and the British […]
During the past 70 years, advances in many scientific and technological areas should have dramatically raised the productivity of biopharma […]
Introduction Historically, the biopharma space has always lagged behind other industries when it comes to digitizing processes. But over the […]
The use of big data in drug research has reached an all-time high in recent years. The demand for faster […]
Introduction There is a constant growth in the volume, complexity and creation speed of data. Therefore, humans are increasingly relying […]
Gender equality remains a persistent challenge within the biotechnology and pharmaceutical industry. Female CEOs account for less than 10% of […]
According to new research from the University of East Anglia in collaboration with Boots UK and Leiden University, four million […]
The growing epidemic of “The Silent Liver Disease” Non-alcoholic fatty liver disease (NAFLD) is experiencing a meteoric rise globally. NAFLD […]
